Ariel Investments Increases Stake in Core Laboratories N.V. (CLB); Microsoft (MSFT) Valuation Rose While Grandfield & Dodd Trimmed Its Position

April 18, 2018 - By Hugh Holland

Microsoft Corporation (NASDAQ:MSFT) Logo

Grandfield & Dodd Llc decreased its stake in Microsoft Corp (MSFT) by 4.12% based on its latest 2017Q4 regulatory filing with the SEC. Grandfield & Dodd Llc sold 20,107 shares as the company’s stock rose 4.63% while stock markets declined. The institutional investor held 467,483 shares of the prepackaged software company at the end of 2017Q4, valued at $39.99M, down from 487,590 at the end of the previous reported quarter. Grandfield & Dodd Llc who had been investing in Microsoft Corp for a number of months, seems to be less bullish one the $739.72 billion market cap company. The stock increased 2.02% or $1.9 during the last trading session, reaching $96.07. About 22.73 million shares traded. Microsoft Corporation (NASDAQ:MSFT) has risen 37.43% since April 18, 2017 and is uptrending. It has outperformed by 25.88% the S&P500.

John W. Rogers increased its stake in Core Laboratories N.V. (CLB) by 9.2% based on its latest 2017Q4 regulatory filing with the SEC. Ariel Investments Llc bought 41,619 shares as the company’s stock declined 1.63% with the market. The hedge fund run by John W. Rogers held 494,100 shares of the oilfield services and equipment company at the end of 2017Q4, valued at $54.13M, up from 452,481 at the end of the previous reported quarter. Ariel Investments Llc who had been investing in Core Laboratories N.V. for a number of months, seems to be bullish on the $5.19B market cap company. The stock increased 0.51% or $0.6 during the last trading session, reaching $117.36. About 236,219 shares traded. Core Laboratories N.V. (NYSE:CLB) has declined 4.05% since April 18, 2017 and is downtrending. It has underperformed by 15.60% the S&P500.

Grandfield & Dodd Llc, which manages about $885.55 million and $936.78M US Long portfolio, upped its stake in Johnson Ctls Intl Plc by 25,847 shares to 466,630 shares, valued at $17.78M in 2017Q4, according to the filing. It also increased its holding in Gilead Sciences Inc (NASDAQ:GILD) by 7,898 shares in the quarter, for a total of 135,968 shares, and has risen its stake in Us Bancorp Del (NYSE:USB).

Investors sentiment decreased to 0.77 in Q4 2017. Its down 0.06, from 0.83 in 2017Q3. It dived, as 39 investors sold MSFT shares while 1012 reduced holdings. 134 funds opened positions while 676 raised stakes. 5.46 billion shares or 0.90% less from 5.51 billion shares in 2017Q3 were reported. Everence Mngmt invested in 175,690 shares or 3.3% of the stock. Wealthfront holds 0.35% or 360,059 shares. Cook & Bynum Management Lc stated it has 209,569 shares. The New York-based Diker Management Ltd Liability has invested 0.48% in Microsoft Corporation (NASDAQ:MSFT). Patten Gru accumulated 1.6% or 47,166 shares. Hanson Mcclain Incorporated reported 0.18% stake. Greylin Mangement has invested 0.05% of its portfolio in Microsoft Corporation (NASDAQ:MSFT). Los Angeles Mgmt Equity Research holds 2.7% or 5.78M shares. Stanley Cap Limited Liability Corp reported 2.55% stake. Lawson Kroeker Management Ne holds 3.67% or 133,446 shares. Credit Cap Invests Limited Liability has 30,500 shares. Jbf Capital stated it has 180,000 shares or 1.94% of all its holdings. Northside Mgmt Limited Liability Company reported 24,104 shares. Baker Avenue Asset Limited Partnership has 197,584 shares. Banced holds 6,526 shares or 0.92% of its portfolio.

Analysts await Microsoft Corporation (NASDAQ:MSFT) to report earnings on April, 26 after the close. They expect $0.85 EPS, up 16.44% or $0.12 from last year’s $0.73 per share. MSFT’s profit will be $6.54 billion for 28.26 P/E if the $0.85 EPS becomes a reality. After $0.96 actual EPS reported by Microsoft Corporation for the previous quarter, Wall Street now forecasts -11.46% negative EPS growth.

Among 37 analysts covering Microsoft Corporation (NASDAQ:MSFT), 29 have Buy rating, 2 Sell and 6 Hold. Therefore 78% are positive. Microsoft Corporation had 172 analyst reports since July 22, 2015 according to SRatingsIntel. As per Friday, January 19, the company rating was maintained by UBS. The stock of Microsoft Corporation (NASDAQ:MSFT) earned “Outperform” rating by RBC Capital Markets on Friday, January 27. The stock has “Sell” rating by Citigroup on Friday, October 27. The stock has “Buy” rating by Credit Suisse on Monday, August 7. The rating was upgraded by Cowen & Co to “Outperform” on Tuesday, May 24. The firm has “Outperform” rating given on Wednesday, January 11 by Wells Fargo. Barclays Capital maintained Microsoft Corporation (NASDAQ:MSFT) rating on Friday, October 23. Barclays Capital has “Overweight” rating and $54.0 target. The firm earned “Buy” rating on Wednesday, January 3 by Piper Jaffray. The stock has “Overweight” rating by Pacific Crest on Tuesday, September 22. The firm earned “Buy” rating on Monday, July 17 by Bank of America.

Since February 16, 2018, it had 0 insider buys, and 3 selling transactions for $930,912 activity.

Among 23 analysts covering Core Laboratories (NYSE:CLB), 12 have Buy rating, 0 Sell and 11 Hold. Therefore 52% are positive. Core Laboratories had 54 analyst reports since August 24, 2015 according to SRatingsIntel. The rating was downgraded by Deutsche Bank on Thursday, January 11 to “Hold”. The rating was maintained by Sterne Agee CRT on Wednesday, September 30 with “Neutral”. On Monday, November 30 the stock rating was upgraded by Guggenheim to “Buy”. The stock has “Buy” rating by RBC Capital Markets on Thursday, July 20. The stock of Core Laboratories N.V. (NYSE:CLB) has “Hold” rating given on Monday, April 24 by ABN Amro. RBC Capital Markets maintained Core Laboratories N.V. (NYSE:CLB) on Thursday, January 28 with “Outperform” rating. The stock of Core Laboratories N.V. (NYSE:CLB) has “Hold” rating given on Thursday, March 23 by Scotia Capital. The firm earned “Outperform” rating on Thursday, August 24 by Credit Suisse. The stock of Core Laboratories N.V. (NYSE:CLB) earned “Overweight” rating by Morgan Stanley on Tuesday, April 19. The stock has “Hold” rating by Piper Jaffray on Tuesday, March 13.

Ariel Investments Llc, which manages about $8.99 billion and $8.86B US Long portfolio, decreased its stake in Perceptron Inc. (NASDAQ:PRCP) by 333,351 shares to 790,617 shares, valued at $7.67 million in 2017Q4, according to the filing. It also reduced its holding in Bio (NYSE:BIO) by 256,724 shares in the quarter, leaving it with 267,520 shares, and cut its stake in Interface Inc. (NASDAQ:TILE).

Investors sentiment decreased to 0.86 in 2017 Q4. Its down 0.21, from 1.07 in 2017Q3. It turned negative, as 52 investors sold CLB shares while 109 reduced holdings. 54 funds opened positions while 85 raised stakes. 49.56 million shares or 0.63% more from 49.25 million shares in 2017Q3 were reported. Suntrust Banks reported 0% stake. Guggenheim Capital Limited Liability has 11,472 shares. Lazard Asset Limited Co invested in 314,039 shares. Cipher Lp has 17,270 shares for 0.15% of their portfolio. Blair William And Company Il owns 5,669 shares. Pub Employees Retirement Association Of Colorado stated it has 8,665 shares. Baystate Wealth Mgmt Ltd Liability Com holds 0% of its portfolio in Core Laboratories N.V. (NYSE:CLB) for 20 shares. Corecommodity Limited Liability Company reported 0.72% in Core Laboratories N.V. (NYSE:CLB). New Mexico Educational Retirement Board holds 10,900 shares. Synovus Fincl holds 0.01% of its portfolio in Core Laboratories N.V. (NYSE:CLB) for 5,878 shares. Group Incorporated One Trading Lp holds 3,525 shares or 0% of its portfolio. Lmr Partners Llp has invested 0.54% in Core Laboratories N.V. (NYSE:CLB). Fifth Third Commercial Bank stated it has 0% in Core Laboratories N.V. (NYSE:CLB). Coldstream Capital holds 3,396 shares. Fdx Advsr holds 16,263 shares.

Microsoft Corporation (NASDAQ:MSFT) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>